Eli Lilly & Co. (LLY)
1247.64
-7.76
(-0.62%)
USD |
NYSE |
Aug 24, 16:00
1249.23
+1.60
(+0.13%)
After-Hours: 20:00
Eli Lilly Price to Book Value : 34.67 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 34.89 |
| August 20, 2026 | 34.58 |
| August 19, 2026 | 35.58 |
| August 18, 2026 | 34.06 |
| August 17, 2026 | 32.88 |
| August 14, 2026 | 32.80 |
| August 13, 2026 | 33.60 |
| August 12, 2026 | 33.91 |
| August 11, 2026 | 33.77 |
| August 10, 2026 | 34.24 |
| August 07, 2026 | 32.95 |
| August 06, 2026 | 33.12 |
| August 05, 2026 | 32.51 |
| August 04, 2026 | 31.00 |
| August 03, 2026 | 31.16 |
| July 31, 2026 | 31.93 |
| July 30, 2026 | 32.10 |
| July 29, 2026 | 33.63 |
| July 28, 2026 | 33.92 |
| July 27, 2026 | 33.28 |
| July 24, 2026 | 33.24 |
| July 23, 2026 | 32.96 |
| July 22, 2026 | 32.32 |
| July 21, 2026 | 32.66 |
| July 20, 2026 | 31.87 |
| Date | Value |
|---|---|
| July 17, 2026 | 32.77 |
| July 16, 2026 | 32.49 |
| July 15, 2026 | 32.14 |
| July 14, 2026 | 32.03 |
| July 13, 2026 | 32.84 |
| July 10, 2026 | 33.03 |
| July 09, 2026 | 33.82 |
| July 08, 2026 | 33.79 |
| July 07, 2026 | 34.34 |
| July 06, 2026 | 33.35 |
| July 02, 2026 | 33.73 |
| July 01, 2026 | 33.12 |
| June 30, 2026 | 33.33 |
| June 29, 2026 | 37.20 |
| June 26, 2026 | 36.54 |
| June 25, 2026 | 34.10 |
| June 24, 2026 | 33.79 |
| June 23, 2026 | 33.48 |
| June 22, 2026 | 33.33 |
| June 18, 2026 | 33.22 |
| June 17, 2026 | 33.63 |
| June 16, 2026 | 33.95 |
| June 15, 2026 | 34.15 |
| June 12, 2026 | 34.26 |
| June 11, 2026 | 35.11 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Johnson & Johnson | 7.739 |
| Merck & Co., Inc. | 8.873 |
| Pfizer Inc. | 1.872 |
| Bristol Myers Squibb Co. | 6.161 |
| Atai Beckley, Inc. | 15.44 |
Price to Book Value Related Metrics
| PE Ratio | 42.39 |
| PS Ratio | 14.22 |
| PEG Ratio | 0.4456 |
| Price to Free Cash Flow | 83.57 |
| Price | 1247.64 |
| Earnings Yield | 2.36% |
| Market Cap | 1.175T |
| PEGY Ratio | 0.4431 |
| Operating PE Ratio | 28.61 |
| Normalized PE Ratio | 36.58 |